Publication excerpt
"A key to success in drug and device litigation is to win the battle of the experts, and a staple strategy in that battle is to limit or exclude the opponent’s experts and protect one’s own. Tactically, the front line in this battle is to effectively undermine the foundations of the opposing experts and then exploit significant weaknesses through motions challenging the admissibility of key parts of their proposed testimony."
- James A. Frederick, Eric M. Friedman & Emilee P. Schipske, Faegre Drinker Biddle & Reath
|
|
|
About the contributing editor
Eric M. Friedman
Faegre Drinker Biddle & Reath
Eric M. Friedman guides clients through all stages of product liability litigation, particularly working with expert witnesses to present the science behind clients’ products. By leaning on his pre-law history as a biochemist, he is able to identify key arguments for and against clients and craft winning strategies for both motion practice and trial. |
|
|
|
|
|
About the International Comparative Legal Guide (ICLG) series:
Since 2003, the ICLG series has been providing practical insights and intelligence on cross-border law to professionals worldwide. The series is divided into 58 key practice areas, each featuring a set of directly comparable, annually updated Q&A chapters covering key jurisdictions, as well as expert analysis chapters giving detailed commentary on issues and trends of global importance.
To become a contributor, please get in touch.
|
|
|
GLOBAL LEGAL GROUP 59 Tanner Street, London, SE1 3PL, UK |
|
|
|
|
|
